Search research articles
Contact Us
Filters
Showing results (141-150 of 144) with videos related to
Page
of 15
Sort By:
You have reached the last page of results.
This site can display upto 144 results.
The American Journal of Cardiology
|
July 29, 2000
Comparison of effects of simvastatin versus atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I levels
J J Kastelein, J L Isaacsohn, L Ose, et al.
American Journal of Human Genetics
|
July 14, 2001
Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively
K Lu, M H Lee, S Hazard, et al.
Clinical Cardiology
|
February 19, 2000
Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study Group
L Ose, M H Davidson, E A Stein, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
February 24, 2001
Lipid-altering efficacy and safety of simvastatin 80 mg/day: worldwide long-term experience in patients with hypercholesterolemia
M H Davidson, E A Stein, D B Hunninghake, et al.
Page
of 15
Search research articles
Search
Showing results (141-150 of 144) with videos related to
Sort By:
Page
of 15
You have reached the last page of results.
This site can display upto 144 results.
The American Journal of Cardiology
|
July 29, 2000
Comparison of effects of simvastatin versus atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I levels
J J Kastelein, J L Isaacsohn, L Ose, et al.
American Journal of Human Genetics
|
July 14, 2001
Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively
K Lu, M H Lee, S Hazard, et al.
Clinical Cardiology
|
February 19, 2000
Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study Group
L Ose, M H Davidson, E A Stein, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
February 24, 2001
Lipid-altering efficacy and safety of simvastatin 80 mg/day: worldwide long-term experience in patients with hypercholesterolemia
M H Davidson, E A Stein, D B Hunninghake, et al.
Page
of 15